The federal judge presiding over the diabetes drug Avandia multidistrict litigation has approved the dispersal of up to $143.75 million in attorney fees.
November 12, 2012 at 12:00 AM
1 minute read
The federal judge presiding over the diabetes drug Avandia multidistrict litigation has approved the dispersal of up to $143.75 million in attorney fees.
The fees make up 6.25 percent of the estimated aggregate value of the settlements in the litigation.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Duane Morris LLP seeks a full-time staff litigation attorney who has practiced between 3-5 years. Experience will include drafting motions, ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
